Venus Remedies gets patent grants for Sulbactomax in Russia, Ukraine
27 December 2010
Related News
-
May 23, 2012 at 16:25
-
May 22, 2012 at 16:25
-
May 21, 2012 at 16:30
-
May 18, 2012 at 15:55
-
May 17, 2012 at 16:30
MUMBAI (makemystocks): Venus Remedies Ltd has got patent grants from Federal Services on Intellectual Property Patents and Trademarks of Russia and Ukrainian Institute of Industrial Property for drug Sulbactomax.
In a press release Monday Venus Remedies said, Sulbactomax has an existing market of $2 million in Ukraine.
Sulbactomax is used for treatment of respiratory tract and urinary tract infections.
The company now has Sulbactomax patent grants in 41 countries, the release said.